You are here:Home-Chemical Inhibitors & Agonists-Nuclear Receptor/Transcription Factor-RAR/RXR-RXR agonist 33
RXR agonist 33

Chemical Structure : RXR agonist 33

CAS No.:

RXR agonist 33

Catalog No.: PC-21720Not For Human Use, Lab Use Only.

RXR agonist 33 is a highly potent, selective and partial RXR agonist with EC50 of 9/18/11 nM for RXRα/β/γ respectively.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

RXR agonist 33 is a highly potent, selective and partial RXR agonist with EC50 of 9/18/11 nM for RXRα/β/γ respectively.
RXR agonist 33 shows favorable selectivity profile with no off-target effect at 1 μM on nuclear receptors related to RXR.
RXR agonist 33 robustly activates human RXR homodimer response element DR1 with EC50 of 0.16 uM.
RXR agonist 33 induces the expression of the RXR homodimer-regulated glycerophosphodiester phosphodiesterase 1 (GDE1) in HT29 cells.

Physicochemical Properties

M.Wt 361.83
Formula C18H20ClN3O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

3-((4-chloro-6-(4,4-dimethyl-3,4-dihydroquinolin-1(2H)-yl)pyrimidin-2-yl)oxy)propanoic acid

References

1. Max Lewandowski, et al. J Med Chem. 2024 Jan 18. doi: 10.1021/acs.jmedchem.3c02095.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: